Alerje Funding & Investors

Detroit, MI

Alerje develops an emergency medicine and digital oral immunotherapy management platform to improve the quality of life for those affected by food allergies. Its online platform and app enable users to create food allergy profiles, share the profiles, filter recipes based on the profiles, and also scan grocery items to detect allergens in the ingredients. It also features an epinephrine auto-injector that integrates into a smartphone case for improved patient adherence and alerts, and its National Science Foundation (NSF) validated food allergy oral immunotherapy (OIT) adherence platform collects, stores, analyzes, and distributes alerts and notifications.